Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lingli Liao"'
Autor:
Jiatao Wu, Lei Zhang, Wenjuan Li, Luyao Wang, Qianhao Jia, Fan Shi, Kairui Li, Lingli Liao, Yuqi Shi, Shiwu Wu
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-17 (2023)
Abstract Type IIA topoisomerase (TOP2A) is significantly associated with malignant tumor development, invasion, treatment and its prognosis, and has been shown to be a therapeutic target against cancer. In contrast, the role of TOP2A in the immunothe
Externí odkaz:
https://doaj.org/article/4846abba039b4a75b7cc5c4f6e22d70c
Autor:
Yongchun Zhou, Lingli Liao, Nan Su, Hua Huang, Yaoguo Yang, Yan Yang, Gengming Wang, Hongbo Xu, Hao Jiang
Publikováno v:
Radiation Medicine and Protection, Vol 3, Iss 3, Pp 139-145 (2022)
Objective: To define the properties of lung cancer cells that resisted conventionally fractionated radiation exposure. Methods: Acquired radioresistant lung cancer cell line A549 was constructed by X-ray irradiation with a clinical conventional fract
Externí odkaz:
https://doaj.org/article/dc3900e7e63f4ffeb53a38da03f5e802
Autor:
Jiatao wu, Lei Zhang, wenjuan Li, Luyao Wang, Kairui Li, Fan Shi, Qianhao Jia, Lingli Liao, Yuqi Shi, Shiwu Wu
Background: Type IIA topoisomerase (TOP2A) is significantly associated with malignant tumor development, invasion, treatment and its prognosis, and has been shown to be a therapeutic target against cancer. In contrast, the role of TOP2A in the immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17735f38db064669db60b35acee25d9f
https://doi.org/10.21203/rs.3.rs-2321012/v1
https://doi.org/10.21203/rs.3.rs-2321012/v1